Stocks and Investing Stocks and Investing
Thu, December 20, 2018
[ 12:00 AM ] - United States, WOPRAI
Christopher Sighinolfi Upgraded (TRGP) to Strong Buy on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Thomas Allen Downgraded (XHR) to Sell and Decreased Target to $17 on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Brad Erickson Initiated (YELP) at Hold on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Michael King Initiated (ANAB) at Strong Buy and Held Target at $126 on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Thomas Allen Upgraded (BYD) to Buy and Decreased Target to $31 on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Richard Shane Upgraded (AGNC) to Buy and Held Target at $18 on, Dec 20th, 2018
[ 12:00 AM ] - United States, WOPRAI
Jordan Sadler Downgraded (BDN) to Hold on, Dec 20th, 2018
Wed, December 19, 2018
[ 12:00 AM ] - United States, WOPRAI
John Freeman Downgraded (AR) to Sell on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Ashwin Shirvaikar Maintained (ACN) at Hold with Decreased Target to $161 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Arvind Ramnani Maintained (ACN) at Buy with Decreased Target to $182 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Craig Hettenbach Downgraded (ADI) to Hold on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Adam Borg Initiated (ADSK) at Strong Buy and Held Target at $163 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Andrew Wittmann Maintained (ABM) at Hold with Decreased Target to $31 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Kenneth Bruce Downgraded (AXP) to Hold and Decreased Target to $115 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $401 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $212 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
William Katz Maintained (AMG) at Strong Buy with Decreased Target to $130 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Chris Shibutani Downgraded (ALKS) to Strong Sell and Decreased Target to $26 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
David Manthey Maintained (SRCL) at Hold with Decreased Target to $44 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Ric Prentiss Maintained (TMUS) at Strong Buy on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Anthony Paolone Initiated (WPC) at Hold and Held Target at $73 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (UBX) at Buy with Decreased Target to $240 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Kelly Crago Initiated (ULTA) at Strong Buy on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Nathan Jones Upgraded (XYL) to Strong Buy and Increased Target to $75 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Praful Mehta Maintained (CMS) at Hold with Increased Target to $52 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $125 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
John Glass Upgraded (BLMN) to Hold on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
William Katz Maintained (BLK) at Strong Buy with Decreased Target to $450 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
William Katz Maintained (TROW) at Hold with Decreased Target to $101 on, Dec 19th, 2018
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (VRTX) at Buy with Decreased Target to $210 on, Dec 19th, 2018

Matthew Harrison Maintained (VRTX) at Buy with Decreased Target to $210 on, Dec 19th, 2018


Published on 2024-10-26 11:20:58 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Decreased Target from $211 to $210 on, Dec 19th, 2018.

Matthew has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew

  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Held Target at $220 on, Friday, October 26th, 2018
  • Christopher Raymond of "Raymond James" Maintained at Buy with Decreased Target to $201 on, Thursday, October 25th, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $192 on, Thursday, October 25th, 2018

Contributing Sources